Dihydroergotamine

Back to search

Molecule Structure

Scientific Name

Dihydroergotamine

Description of the Drug

Dihydroergotamine is an ergot alkaloid used in the acute treatment of migraine headache and cluster headache.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00320

Brand Name(s)

Not Available

Company Owner(s)

Cipla Ltd, Padagis Us Llc, Sagent Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Hikma Pharmaceuticals, Provepharm Sas, Impel Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Hikma Pharmaceuticals Usa Inc, Bausch Health Us Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Serotonin 1d (5-HT1d) receptor SINGLE PROTEIN AGONIST CHEMBL1983

Unichem Links

SureChEMBL SCHEMBL44931
PharmGKB PA164743028
Human Metabolome Database HMDB0014465
DrugBank DB00320
PubChem: Thomson Pharma 14935810 14788984
PubChem 10531
NMRShiftDB 70102981
LINCS LSM-3619
Nikkaji J6.263D
PDBe 2GM
BindingDB 50295557
EPA CompTox Dashboard DTXSID6045614
DrugCentral 888
Metabolights MTBLC4562
Brenda 201322
Guide to Pharmacology 121
rxnorm DIHYDROERGOTAMINE DHE-45 DIHYDROERGOTAMINE MESYLATE
KEGG Ligand C07798
ChEBI 4562
ZINC ZINC000003978005